A study in the Journal of Clinical Psychiatry showed that people with Tourette syndrome often have difficulty breathing or swallowing, and that it is a significant barrier to treatment.
The authors of the study, Dr. Arvind B. Srinivasan and Dr. Jayadev Srinivasa Rao, said the findings, which appear in the July issue of the Journal, were not limited to patients with Tourettes.
“Treating Tourette sufferers with hyperkalaemic medication may help them overcome the physical symptoms and the social and emotional challenges of their condition,” the researchers wrote.
“However, the effect of hyperkalinemia on the immune system and the development of the nervous system will require careful clinical studies.”
The study also found that the people with the highest risk of developing Tourette had a significantly lower rate of clinical remission compared to people who were not diagnosed with the condition.
The study found that, in terms of clinical response, people with a higher risk of being diagnosed with Tourethests were more likely to relapse to Tourette as well as to have more episodes of severe anxiety.
Sixty percent of the people who had an episode of severe panic attacks and 40 percent of those with Tourians had symptoms that resembled those of Tourette, the researchers noted.
The researchers noted that although it is unclear whether the people diagnosed with a Tourette diagnosis are actually more likely or less likely to have a clinical response compared to those who do not, there are two main reasons why.
“First, the number of episodes of Tourethest episodes is significantly lower among Tourette-affected patients,” the authors wrote.
Another reason is that patients with a more severe Tourette are at higher risk for developing an autoimmune disease such as psoriasis, rheumatoid arthritis or arthritis-like arthritis, and are more likely than other people to have the autoimmune disease.
Surgical intervention is often needed to help treat the Tourette symptoms, according to the study.
The symptoms of Tourettess are so severe that they often require hospitalization and are often treated with sedation, anesthesia or a sedative.
There are no specific therapies for Tourette patients, though there are some medications that can be used.
The treatments are often limited to milder versions of the symptoms, and they do not treat the underlying causes of the Tourettish.
However, Srinaprasan and Rao said that there are several possible treatments that may help Tourette treatment.
For instance, they said, hyperkaline medication may be an option for patients who are unable to take other medications that do not interfere with the brain’s response to tics.
There is also a treatment called hyperkali-fusion, which is used to help patients tolerate high doses of a drug used to treat narcolepsy, a disorder that can affect the central nervous system.
However the authors of that study did not report whether the treatment had any clinical benefit for patients with mild Tourette.
In addition to the clinical trials, the authors said they are continuing to study whether hyperkalo-cinerea or other hyperkaltic medications could also be effective in treating Tourette disorder.